86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04915300 (ClinicalTrials.gov)	October 2022	19/5/2021	Apabetalone for Pulmonary Arterial Hypertension	Apabetalone for Pulmonary Arterial Hypertension: a Phase 2 Clinical Study	Pulmonary Arterial Hypertension	Drug: Apabetalone;Drug: Placebo	Laval University	Canadian Institutes of Health Research (CIHR);Resverlogix Corp	Not yet recruiting	18 Years	75 Years	All	72	Phase 2	Canada
2	NCT03655704 (ClinicalTrials.gov)	August 22, 2019	28/8/2018	Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study	Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study	Pulmonary Arterial Hypertension	Drug: Apabetalone	Steeve Provencher	Resverlogix Corp	Completed	18 Years	75 Years	All	7	Early Phase 1	Canada

First Previous1Next Last